CX3CL1 and neoplasm: With progressive ADM expression decline, transcriptional levels of pro-tumorigenic inflammatory cytokines IL1B and CX3CL1 demonstrated gradual downregulation, suggesting elevated ADM expression may accelerate tumor progression through pro-inflammatory microenvironment enrichment.